Characterization of a Novel Pathogen in Immunocompromised Patients: Elizabethkingia anophelis -Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and β-lactamase Inhibitors.

Mohamad YasminLaura J RojasSteven H MarshallAndrea M HujerAnna CmolikEmma MarshallHelen W BoucherAlejandro J VilaMaxime SoldevilaSeydina M DieneJean-Marc RolainRobert A Bonomo

Published in: Open forum infectious diseases (2023)

in an immunocompromised patient. Rapid evaluation of the genetic background can guide accurate susceptibility testing to better inform antimicrobial therapy selection.

Keyphrases

end stage renal disease
staphylococcus aureus
ejection fraction
newly diagnosed
chronic kidney disease
case report
multidrug resistant
gene expression
respiratory failure
patient reported outcomes
copy number
gram negative
cell therapy